Literature DB >> 21490239

Modification of menopausal hormone therapy-associated colorectal cancer risk by polymorphisms in sex steroid signaling, metabolism and transport related genes.

Anja Rudolph1, Juan Sainz, Rebecca Hein, Michael Hoffmeister, Bernd Frank, Asta Försti, Hermann Brenner, Kari Hemminki, Jenny Chang-Claude.   

Abstract

The mechanisms underlying the association of menopausal hormone therapy (MHT) with reduced colorectal cancer (CRC) risk are unknown and the identification of genetic modifiers may yield further insight. We explored the effect modification of MHT-associated CRC risk in postmenopausal women by 47 polymorphisms with known or putative functional relevance in 16 candidate genes related to hormone metabolism (COMT, CYP1A1, CYP1A2, CYP1B1, CYP2C9, CYP2C19, CYP3A4, CYP17A1, GSTP, and HSD17B1), transport (ABCB1), and signaling (ESR1, ESR2, SHBG, PGR, and NR1I2). A total of 685 CRC patients and 684 healthy controls from a German population-based case-control study (DACHS) were genotyped. Multiplicative statistical interaction between polymorphisms and ever MHT use as well as duration of use was assessed using multivariate logistic regression. CRC risk associated with ever MHT use as well as with duration was significantly modified by rs1202168 in the transporter gene ABCB1 (P interaction=0.04). The MHT-associated risk reduction was not significant in homozygous non-carriers (odds ratio (OR) ever use=0.84, 95% confidence interval (CI) 0.53-1.34; OR per 5 year duration=0.94, 95% CI 0.83-1.08), while homozygous carriers of the minor T allele had a 57% lower risk with ever use of MHT (95% CI 0.21-0.88) and a 22% lower risk per 5 years of MHT use (95% CI 0.62-0.97). Significant effect modification was also observed for the ESR1_rs910416 polymorphism (P interaction=0.03 for ever use and 0.07 for duration of use), whereby the decreased risk was attenuated in homozygous carriers of the minor C allele (OR ever use=0.87, 95% CI 0.48-1.60, OR per 5 year duration=0.99, 95% CI 0.83-1.18). Results of this exploratory study provide first evidence that polymorphisms in genes related to estrogen transport and signaling may modify MHT-associated CRC risk but warrant replication in an independent population.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21490239     DOI: 10.1530/ERC-11-0057

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  17 in total

1.  Genetic variation in insulin pathway genes and distal colorectal adenoma risk.

Authors:  A Joan Levine; Ugonna Ihenacho; Won Lee; Jane C Figueiredo; David J Vandenberg; Christopher K Edlund; Brian D Davis; Mariana C Stern; Robert W Haile
Journal:  Int J Colorectal Dis       Date:  2012-05-30       Impact factor: 2.571

2.  Association between the CYP1A2 polymorphisms and risk of cancer: a meta-analysis.

Authors:  Wen-Xia Sun; Ying-Hua Chen; Zhi-Zhong Liu; Jian-Jun Xie; Wei Wang; Ya-Ping Du; Yu Chen; Xu-Liang Shen; Xiao-Feng He; Li-Xia Wu; Wu Wei; Lin Zhang
Journal:  Mol Genet Genomics       Date:  2014-12-04       Impact factor: 3.291

3.  Association between the CYP1B1 polymorphisms and risk of cancer: a meta-analysis.

Authors:  Jie-Ying Liu; Yu Yang; Zhi-Zhong Liu; Jian-Jun Xie; Ya-Ping Du; Wei Wang
Journal:  Mol Genet Genomics       Date:  2014-12-05       Impact factor: 3.291

Review 4.  Association between the CYP1A2-164 A/C polymorphism and colorectal cancer susceptibility: a meta-analysis.

Authors:  Jianbing Hu; Chuan Liu; Qinghua Yin; Mingzhen Ying; Junhui Li; Lian Li; Chun-xia Zhou; Yajie Wang
Journal:  Mol Genet Genomics       Date:  2014-02-11       Impact factor: 3.291

5.  CYP1B1 Leu432Val polymorphism and colorectal cancer risk among Caucasians: a meta-analysis.

Authors:  Yong Xie; Guo-Qing Liu; Xiong-Ying Miao; Yi Liu; Wei Zhou; De-Wu Zhong
Journal:  Tumour Biol       Date:  2011-12-22

6.  Genome-Wide Interaction Analysis of Genetic Variants With Menopausal Hormone Therapy for Colorectal Cancer Risk.

Authors:  Yu Tian; Andre E Kim; Stephanie A Bien; Yi Lin; Conghui Qu; Tabitha A Harrison; Robert Carreras-Torres; Virginia Díez-Obrero; Niki Dimou; David A Drew; Akihisa Hidaka; Jeroen R Huyghe; Kristina M Jordahl; John Morrison; Neil Murphy; Mireia Obón-Santacana; Cornelia M Ulrich; Jennifer Ose; Anita R Peoples; Edward A Ruiz-Narvaez; Anna Shcherbina; Mariana C Stern; Yu-Ru Su; Franzel J B van Duijnhoven; Volker Arndt; James W Baurley; Sonja I Berndt; D Timothy Bishop; Hermann Brenner; Daniel D Buchanan; Andrew T Chan; Jane C Figueiredo; Steven Gallinger; Stephen B Gruber; Sophia Harlid; Michael Hoffmeister; Mark A Jenkins; Amit D Joshi; Temitope O Keku; Susanna C Larsson; Loic Le Marchand; Li Li; Graham G Giles; Roger L Milne; Hongmei Nan; Rami Nassir; Shuji Ogino; Arif Budiarto; Elizabeth A Platz; John D Potter; Ross L Prentice; Gad Rennert; Lori C Sakoda; Robert E Schoen; Martha L Slattery; Stephen N Thibodeau; Bethany Van Guelpen; Kala Visvanathan; Emily White; Alicja Wolk; Michael O Woods; Anna H Wu; Peter T Campbell; Graham Casey; David V Conti; Marc J Gunter; Anshul Kundaje; Juan Pablo Lewinger; Victor Moreno; Polly A Newcomb; Bens Pardamean; Duncan C Thomas; Konstantinos K Tsilidis; Ulrike Peters; W James Gauderman; Li Hsu; Jenny Chang-Claude
Journal:  J Natl Cancer Inst       Date:  2022-08-08       Impact factor: 11.816

7.  Genetic variants in sex hormone metabolic pathway genes and risk of esophageal squamous cell carcinoma.

Authors:  Paula L Hyland; Neal D Freedman; Nan Hu; Ze-Zhong Tang; Lemin Wang; Chaoyu Wang; Ti Ding; Jin-Hu Fan; You-Lin Qiao; Asieh Golozar; William Wheeler; Kai Yu; Jeff Yuenger; Laurie Burdett; Stephen J Chanock; Sanford M Dawsey; Margaret A Tucker; Alisa M Goldstein; Christian C Abnet; Philip R Taylor
Journal:  Carcinogenesis       Date:  2013-01-28       Impact factor: 4.944

Review 8.  CYP1A1 and GSTP1 gene variations in breast cancer: a systematic review and case-control study.

Authors:  Sumaira Akhtar; Ishrat Mahjabeen; Zertashia Akram; Mahmood Akhtar Kayani
Journal:  Fam Cancer       Date:  2016-04       Impact factor: 2.375

9.  Repeat polymorphisms in ESR2 and AR and colorectal cancer risk and prognosis: results from a German population-based case-control study.

Authors:  Anja Rudolph; Hong Shi; Asta Försti; Michael Hoffmeister; Juan Sainz; Lina Jansen; Kari Hemminki; Hermann Brenner; Jenny Chang-Claude
Journal:  BMC Cancer       Date:  2014-11-07       Impact factor: 4.430

10.  Association between CYP1A2 and CYP1B1 polymorphisms and colorectal cancer risk: a meta-analysis.

Authors:  Xiao-Feng He; Jie Wei; Zhi-Zhong Liu; Jian-Jun Xie; Wei Wang; Ya-Ping Du; Yu Chen; Hui-Qiang Si; Qing Liu; Li-Xia Wu; Wu Wei
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.